000 | 01424 a2200445 4500 | ||
---|---|---|---|
005 | 20250513120200.0 | ||
264 | 0 | _c19970520 | |
008 | 199705s 0 0 eng d | ||
022 | _a0340-6245 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aSmith, M P | |
245 | 0 | 0 |
_aSuccessful clinical use of a plasma-derived, dual virus inactivated factor VII concentrate incorporating solvent-detergent and dry heat treatment. _h[electronic resource] |
260 |
_bThrombosis and haemostasis _cFeb 1997 |
||
300 |
_a406-7 p. _bdigital |
||
500 | _aPublication Type: Letter | ||
650 | 0 | 4 | _aAdolescent |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aBlood _xdrug effects |
650 | 0 | 4 | _aChild |
650 | 0 | 4 |
_aDetergents _xpharmacology |
650 | 0 | 4 | _aDrug Evaluation |
650 | 0 | 4 |
_aFactor VIII _ximmunology |
650 | 0 | 4 | _aFreeze Drying |
650 | 0 | 4 |
_aHemophilia A _xdrug therapy |
650 | 0 | 4 |
_aHepatovirus _xdrug effects |
650 | 0 | 4 | _aHot Temperature |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aIsoantibodies _xbiosynthesis |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aOrganophosphates _xpharmacology |
650 | 0 | 4 |
_aParvovirus, Canine _xdrug effects |
650 | 0 | 4 |
_aPolysorbates _xpharmacology |
650 | 0 | 4 | _aSafety |
650 | 0 | 4 |
_aSolvents _xpharmacology |
650 | 0 | 4 |
_aVirus Diseases _xprevention & control |
700 | 1 | _aRice, K M | |
700 | 1 | _aSavidge, G F | |
773 | 0 |
_tThrombosis and haemostasis _gvol. 77 _gno. 2 _gp. 406-7 |
|
999 |
_c9138867 _d9138867 |